Digestives & Intestinal Remedies - Kuwait

  • Kuwait
  • In Kuwait, the revenue in the Digestives & Intestinal Remedies market market is recorded at US$44.51m in 2024.
  • Looking ahead, the market is projected to experience an annual growth rate of 0.75% (CAGR 2024-2029).
  • When compared to other countries worldwide, in China stands out as the top revenue generator, with a staggering US$4,408.00m in 2024.
  • In terms of per person revenues, Kuwait's figure amounts to US$10.23 in 2024.
  • Kuwait's demand for Digestives & Intestinal Remedies in the OTC Pharmaceuticals market is driven by its high prevalence of gastrointestinal disorders and the increasing adoption of Western dietary habits.

Key regions: Brazil, India, United Kingdom, Germany, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestives & Intestinal Remedies market in Kuwait is experiencing steady growth due to increasing customer preferences for natural and herbal remedies, as well as a rise in gastrointestinal disorders. Customer preferences in the Digestives & Intestinal Remedies market in Kuwait are shifting towards natural and herbal remedies. Consumers are becoming more health-conscious and are seeking products that are perceived to be safer and have fewer side effects. This has led to a growing demand for natural remedies such as herbal teas, dietary supplements, and probiotics. Additionally, there is a growing preference for products that are free from artificial ingredients and preservatives. Another factor driving the growth of the market is the increasing prevalence of gastrointestinal disorders in Kuwait. Factors such as a sedentary lifestyle, unhealthy eating habits, and stress contribute to the rise in digestive issues such as acid reflux, indigestion, and irritable bowel syndrome. As a result, there is a higher demand for products that provide relief from these conditions. Trends in the Digestives & Intestinal Remedies market in Kuwait include the introduction of innovative products and the expansion of distribution channels. Companies are launching new products with unique formulations and ingredients to cater to the evolving preferences of consumers. For example, probiotic supplements and digestive enzymes are gaining popularity as they are believed to support gut health. Additionally, companies are expanding their distribution networks to reach a wider customer base. This includes partnering with pharmacies, supermarkets, and online platforms to make their products more accessible to consumers. Local special circumstances in Kuwait that impact the Digestives & Intestinal Remedies market include a growing population of expatriates and a high prevalence of stress-related digestive disorders. Kuwait has a large expatriate population, who often face challenges in adapting to the local diet and lifestyle. This can lead to digestive issues and an increased demand for remedies to alleviate these symptoms. Furthermore, the fast-paced and stressful nature of modern life in Kuwait can contribute to a higher incidence of stress-related digestive disorders, creating a need for products that address these specific concerns. Underlying macroeconomic factors that contribute to the growth of the Digestives & Intestinal Remedies market in Kuwait include a stable economy and increasing healthcare expenditure. Kuwait has a strong economy driven by oil exports, which provides consumers with higher purchasing power. This allows them to afford healthcare products and invest in their well-being. Additionally, the government of Kuwait has been increasing its healthcare expenditure, which supports the development and availability of healthcare products, including Digestives & Intestinal Remedies. Overall, the Digestives & Intestinal Remedies market in Kuwait is growing due to shifting customer preferences, an increasing prevalence of gastrointestinal disorders, and favorable macroeconomic factors. Companies in the market are responding to these trends by introducing innovative products and expanding their distribution networks to cater to the evolving needs of consumers.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)